-
Anderson TW et al. A double-blind trial of vitamin E in angina pectoris. Am J
Clin Nutr 27:1174-8, 1974.
-
Azen SP, Qian D, Mack W, et al. Effect of supplementary antioxidant vitamin
intake on carotid arterial wall intima-media thickness in a controlled clinical
trial of cholesterol lowering. Circulation 94;10:2369-72, 1996.
-
Barboriak JJ et al. Vitamin E supplements and plasma high-density lipoprotein
cholesterol. Letter. Am J Clin Pathol 77;3:371, 1982.
-
Bellizzi MC, Franklin MF, Duthie GG, et al. Vitamin E and coronary heart
disease: the European paradox. Eur J Clin Nutr 48:822-31, 1994.
-
Bierenbaum M, Reichstein R, Bhagavan H, et al. Relationship between serum lipid
peroxidation products in hypercholesterolemic subjects and vitamin E status.
Biochem Int 28:57-66, 1992.
-
Boers GH. Hyperhomocysteinaemia: a newly recognized risk factor for vascular
disease. Neth J Med 45:1:34-41, 1994.
-
Boniton-Kopp C, Coudray C, Berr C, et al. Combined effects of lipid peroxidation
and antioxidant status on carotid atherosclerosis in a population aged 59-71 y:
The Eva study.Am J Clin Nutr 65:121-7, 1997.
-
Bordia A et al. Effect of vitamin C on platelet adhesiveness and platelet
aggregation in coronary artery disease patients. Clin Cardiol 810:552-4, 1985.
-
Brattström L et al. Impaired homocysteine metabolism in early-onset cerebral and
peripheral occlusive arterial disease. Effects of pyridoxine and folic acid
treatment. Atherosclerosis 81:1:51-60, 1990.
-
Brattström L, Stavenow L, Galvard H, et al. Pyridoxine reduces cholesterol and
low-density-lipoprotein and increases antithrombin III activity in 80- year-old
men with low plasma pyridoxal 5-phosphate. Scand J Clin Lab Invest 50:8:873-7,
1990.
-
Brattström L. Vitamins as homocysteine-lowering agents: a mini review.
Presentation at the American Institute of Nutrition Colloquium, April 13, 1995,
Atlanta, Georgia; Brattström L. Vitamins as homocysteine-lowering agents. J Nutr
126:4 Suppl:1276S-1280S, 1996.
-
Calzada C, Bruckdorfer K, Rice-Evans C. The influence of antioxidant nutrients
on platelet function in healthy volunteers. Atherosclerosis 128;1:97-105, 1997.
-
Campos AM, Lissi EA, Total antioxidant potential of Chilean wines. Nutr Res
16:385-9, 1996.
-
Carpenter KLH, Cheeseman KH, Van Der Veen C, et al. Depletion of
alpha-tocopherol in human atherosclerotic lesions. Free Rad Res 23:549- 58,
1995.
-
Cavarocchi NC et al. Superoxide generation during cardiopulmonary bypass: Is
there a role for vitamin E? J Surg Res 40:519-27, 1986.
-
Chakrabarty S, Nandi A, Mukhopadhyay C, et al. Protective role of ascorbic acid
against lipid peroxidation and myocardial injury. Mol Cell Biochem 111:41-7,
1992.
-
Chamiec T et al. Effects of antioxidant vitamins C and E on signal-averaged
electro-cardiogram and acute myocardial infarction. Am J Cardiol 77:237-41,
1996.
-
Choi ESK et al. Correlation of plasma ascorbic acid with cardiovascular risk
factors. Am J Clin Nutr 51:511, 1990.
-
Cloarec MJ et al. Alpha-tocopherol: Effect on plasma lipoproteins in
hypercholesterolemic patients. Isr J Med Sci 23;8:869-72, 1987.
-
Coghlan JG, Flitter WD, Clutton SM, et al. Lipid peroxidation and changes in
vitamin E levels during coronary artery bypass grafting. J Thorac Cardiovasc
Surg 106;2:268-74, 1993.
-
Creter D et al. Effect of vitamin E on platelet aggregation in diabetic
retinopathy. Acta Hematol 62:74, 1979.
-
Dalery K et al. Homocysteine and coronary artery disease in French Canadian
subjects: relation with vitamins B12, B6, pyridoxal phosphate and folate. Am J
Cardiol 75:1107-11, 1995.
-
Dallal GE et al. Ascorbic acid, HDL cholesterol, and apolipoprotein A-I in an
elderly Chinese population in Boston. J Am Coll Nutr 8;1:69-74, 1989.
-
De Lorgeril , Boissonnat P, Salen P, et al. The beneficial effect of dietary
antioxidant supplementation on platelet aggregation and cyclosporine treatment
in heart transplant recipients. Transplantation 58:193-4, 1994.
-
DeMaio SJ et al. Vitamin E supplementation, plasma lipids and incidence of
restenosis after percutaneous transluminal coronary angioplasty PTCA. J Am Coll
Nutr 11;1:68-73, 1992.
-
Dieber-Rotheneder M et al. Effect of oral supplementation with
D-alpha-tocopherol on the vitamin E content of human low density lipoproteins
and resistance to oxidation. J Lipid Res 32:1325- 32, 1991.
-
Dobson HM et al. The effect of ascorbic acid on the seasonal variations in serum
cholesterol levels. Scot Med J 293:176-82, 1984.
-
Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of
the United States population. Epidemiology 3:3:194-202, 1992.
-
Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes
mellitus. Ann Nutr Metab 394:217-23, 1995.
-
Esk C et al. Correlation of plasma ascorbic acid with cardiovascular risk
factors. Clin Res 38:A747, 1990.
-
Ferreira R et al. Antioxidant action of vitamins A and E in patients submitted
to coronary bypass surgery. Vasc Surg 25:191-5, 1991.
-
Gartside PS, Glueck CJ. Relationship of dietary intake to hospital admission for
coronary heart and vascular disease: The NHANES II National Probability Study. J
Am Coll Nutr 12:6:5676-84, 1993.
-
Gatto LM, Hallen GK, Brown AJ, Samman S. Ascorbic acid induces a favorable
lipoprotein profile in women. J Am Coll Nutr 152:154-8, 1996.
-
Gey KF et al. Inverse correlation between plasma vitamin E and mortality from
ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr
53:326S-34S, 1991.
-
Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C
is associated with higher mortality from ischemic heart disease and stroke:
Basel Prospective Study. Clin Invest 71:3-6, 1993.
-
Ginter E et al. Vitamin C in the control of hypercholesterolemia in man. Int J
Vitam Nutr Res Suppl 23:137-52, 1982; Turley S et al. Role of ascorbic acid in
the regulation of cholesterol metabolism and the pathogenesis of
atherosclerosis. Atherosclerosis 24:1-18, 1976.
-
Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in
health and disease: a hospital-based case-control study. J Nutr Environ Med
5:235-42, 1995.
-
Gribauskas P et al. [Manganese levels in hair as an additional indicator for
early diagnosis of ischemic disease of the heart.] Lab Delo ;10:629, 1985.
-
Hallfrisch J et al. High plasma vitamin C associated with increased plasma HDL-
and HDL 2 -cholesterol. Clin Res 39:A203, 1991.
-
Hallfrisch J, Singh VN, Muller DC, et al. High plasma vitamin C associated with
high plasma HDL-and HDL2 cholesterol. Am J Clin Nutr 60:100-5, 1994.
-
Hennig B et al. Protective effects of vitamin E in age-related endothelial cell
injury. Int J Vitam Nutr Res 59:273-9, 1989.
-
Hennig B. Mechanisms of atherosclerosis: Nutrition and endothelial cell
integrity. Abstract. J Am Coll Nutr 12:594, 1993.
-
Herbaczynska-Cedro K, Klosiewicz-Wasek B, Cedro K, et al. Supplementation with
vitamins C and E suppresses leukocyte oxygen free radical production in patients
with myocardial infarction. Eur Heart J 16:1044-9, 1995.
-
Hermann WJ et al. The effect of tocopherol on high-density lipoprotein
cholesterol: A clinical observation. Am J Clin Pathol 72:848-52, 1979.
-
Hodis HN, Mack WJ, LaBree L, et al. Serial coronary angiographic evidence that
antioxidant vitamin intake reduces progression of coronary artery
atherosclerosis. JAMA 273;23:1849-54, 1995.
-
Horsey J, Livesley B, Dickerson JW. Ischemic heart disease and aged patients:
effects of ascorbic acid on lipoproteins. J Hum Nutr 35:1:53-8, 1981.
-
Jacques PF et al. Ascorbic acid, HDL, and total plasma cholesterol in the
elderly. J Am Coll Nutr 6;2:169-74, 1987.
-
Jacques PF. Effects of vitamin C on high-density lipoprotein cholesterol and
blood pressure. J Am Coll Nutr 11;2:139-44, 1992.
-
Jacques PF, Sulsky SI, Perrone GA, Schaefer EJ. Ascorbic acid and plasma lipids.
Epidemiology 5:19-24, 1994.
-
Jacques PF, Sulsky SI, Perrone GE, et al. Effect of vitamin C supplementation on
lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations. Ann
Epidemiol 51:52-9, 1995.
-
Jain SK, McVie R, Jaramillo JJ, et al. The effect of modest vitamin E
supplementation on lipid peroxidation products and other cardiovascular risk
factors in diabetic patients. Lipids 31:S87-90, 1996.
-
Jandak J et al. Reduction of platelet adhesiveness by vitamin E supplementation
in humans. Thrombosis Res 49:393-404, 1988.
-
Jandak J et al. Alpha tocopherol, an effective inhibitor of platelet adhesion.
Blood 73:141-9, 1989.
-
Jenkins David JA et al. Effect of a diet high in vegetables, fruit, and nuts on
serum lipids. Metabolism 46:5:530-37, 1997.
-
Jenkens DJ. Optimal diet for reducing the risk of arteriosclerosis. Can J
Cardiol 11Suppl G:118G-121G, 1995.
-
Jialal I, Vega Gl, Grundy SM. Physiologic levels of ascorbate inhibit the
oxidative modification of low density lipoprotein. Atherosclerosis 82:185-91,
1990.
-
Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on
the oxidative modification of low density lipoprotein. J Lipid Res 33;6:899-906,
1992.
-
Jialal L, Fuller CJ, Hunt BA. The effect of alpha-tocopherol supplementation on
LDL oxidation. Arterioscler Thromb Vasc Biol 15:190-8, 1995.
-
Kang SS. Treatment of hyperhomocysteeinemia: physiological basis. J Nutr 126:4
Suppl:1273S-5S, 1996.
-
Key TJA et al. Dietary habits and mortality in 11,000 vegetarians and health
conscious people: Results of a 17 year follow up. BMJ 313:775-9, 1996.
-
Khaw K-T, et al. Lancet, Vol. 357; 9257: p. 657-663.
-
Khaw K-T, Woodhouse P. Interrelation of vitamin C, infection, hemostatic factors
and cardiovascular disease. BMJ 310:1559-63, 1995.
-
Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intake and coronary
mortality in an longitudinal population study. Am JEpidemiol 139:1180-9, 1994.
-
Kok FJ et al. Low vitamin B6 status in patients with acute myocardial
infarction. Am J Cardiol 63:513-16, 1989.
-
Kok FJ et al. Decreased selenium levels in acute myocardial infarction. JAMA
261;8:1161-4, 1989.
-
Kornecki E, Feinberg H. Mechanism of inhibition of thrombin-induced platelet
aggregation by pyridoxal phosphate. Biochem Biophys Res Commun 90:3:963-8, 1979.
-
Korpela H et al. Effect of selenium supplementation after acute myocardial
infarction. Res Commun Chem Pathol Pharmacol 65:249-52, 1989.
-
Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid
artery wall thickness: the ARIC study. Circulation 92:8:2142-50, 1995.
-
Kunisaki M, Umeda P, Inoguchi T, et al. Vitamin E binds to specific binding
sites and enhances prostacyclin production by cultured aortic endothelial cells.
Thromb Haemost 68:744-51, 1992.
-
Kushi KH, olsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death
from coronary heart disease in postmenopausal women. N Engl J Med 334:1156-62,
1996.
-
Kuzuya F. Arteriosclerosis in pyridoxine deficient-monkeys. Primates 2:99, 1959.
-
Kuzuya F F. Experiment on arteriosclerosis and arteriolosclerosis induced in
pyridoxine-deficient monkeys and their recovery. Primates 3:77, 1962.
-
Kuzuya F. Reversibility of arteriosclerosis in pyridoxine-deficient monkeys, in
G Schettler, Y Goto, Y Hata, G Klose, Eds. Atherosclerosis IV. Berlin,
Springer-Verlag, 1977:275-8.
-
Kuzuya F. Vitamin B6 and arteriosclerosis. Nagoya J Med Sci 55:1-4:1-9, 1993.
-
Lam SC et al. Investigation of possible mechanisms of pyridoxal-5-phosphate
inhibition of platelet reactions. Thrombosis Res 20:633-45, 1980.
-
Lefavi R. Lipid-lowering effects of a dietary nicotinic acid-chromium III
complex in male athletes. FASEB J 5;6:A1645, 1991.
-
Lefavi R et al. Lipid-lowering effect of a dietary chromium III-nicotinic acid
complex in male athletes. Nutr Res 13:239-49, 1993.
-
Levene CI, Murray JC. The aetiological role of maternal B6 deficiency in the
development of atherosclerosis. Lancet i:628, 1977.
-
Levine GN, Frei B, Koulouris SN, et al. Ascorbic acid reverses endothelial
vasomotor dysfunction in patients with coronary artery disease. Circulation
93:6:1107-13, 1996.
-
Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and
risk of all-cause and coronary heart disease mortality in older persons: the
Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr
64:190-6, 1996.
-
Lynch S, Klevay L. Effects of a dietary copper deficiency on plasma coagulation
factor activities in male and female mice. J Nutr Biochem 3:387, 1992.
-
Mancini M et al. Antioxidants in the Mediterranean diet. Can J Cardiol 11Suppl
G:105-9, 1995.
-
Manson JE, Stampfer MJ, Willett WC, et al. A prospective study of antioxidant
vitamins and incidence of coronary heart disease in women. Abstract. J Am Coll
Nutr 11:5:633, 1992.
-
McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis
22:2:215-27, 1975.
-
Meleady RA et al. Genes, greens, and homocysteine. Heart 76:103-4, 1996.
-
Mezzetti A, Lapenna D, Pierdomenico SD, et al. Vitamins E, C and lipid
peroxidation in plasma and arterial tissue of smokers and nonsmokers.
Atherosclerosis 112:91-9, 1995.
-
Miwa K, Miyagi Y, Igawa A, et al. Vitamin E deficiency in variant angina.
Circulation 94;1:14-18, 1996.
-
Moore JA et al. Selenium concentrations in plasma of patients with
arteriographically defined coronary atherosclerosis. Clin Chem 30:1171, 1984.
-
Muckle T, Hazir D. Variation in human blood high-density lipoprotein response to
oral vitamin E megadosage. Am J Clin Pathol 91:165-71, 1989.
-
Mudd SH et al. The natural history of homocystinuria due to cystathionine
beta-synthase deficiency. Am J Hum Genet 37:1:1-31, 1985.
-
Mushett CW, Emerson G. Arteriosclerosis in pyridoxine-deficient monkeys and
dogs. Fed Proc 4:526-7, 1956.
-
Ness A, Khaw K, Bingham S, Day NE. Vitamin C status and serum lipids. Eur J Clin
Nutr 50; 11:724-9, 1996.
-
Novelli GP et al. Vitamin E protects human skeletal muscle from damage during
surgical ischemia-reperfusion. Am J Surg March 173:206-9, 1997.
-
Nyyssonen K et al. Vitamin C deficiency and risk of myocardial infarction:
prospective population study of men from Eastern Finland. BMJ 314:634-8, 1997.
-
Ohvall M et al. Gamma, but not alpha tocopherol levels in serum are reduced in
coronary heart disease patients. J Int Med 239:111-17, 1996.
-
Olszewski AJ et al. Reduction of plasma lipid and homocysteine levels by
pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in
atherosclerosis. Atherosclerosis 75:1:1-6, 1989.
-
Oster O et al. The serum selenium concentration of patients with acute
myocardial infarction. Ann Clin Res 18;1:36-42, 1986.
-
Pories WJ, Henzel JH, Hennessen JA. Proc U of Missouri First Annual Conference
on Trace Substances in the Environment and Health, 1967. 1968:114.
-
Porkkala-Sarataho E, Nyyssonen K , Salonen JT. Increased oxidation resistance of
atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin e
supplemented men. Atherosclerosis 124;1:83-94, 1996.
-
Princen H, van Poppel G, Vogelezang C, et al. Supplementation with vitamin E but
not beta carotene in vivo protects low density lipoprotein from lipid
peroxidation in vitro: Effect of cigarette smoking. Arter Throm 12:554-62, 1992.
-
Princen HM, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low
doses of vitamin E protects LDL from lipid peroxidation in men and women.
Arterioscler Thromb Vasc Biol 15:325-33, 1995.
-
Ramirez J, Flowers NC. Leukocyte ascorbic acid and its relationship to coronary
artery disease in man. Am J Clin Nutr 3:10:2079-87, 1980.
-
Rath M, Pauling L. Solution to the puzzle of human cardiovascular disease: its
primary cause is ascorbate deficiency leading to the deposition of lipoprotein a
and fibrinogen/fibrin in the vascular wall. J Orthomol Med 6:3-4:125-34, 1991.
-
Rath M, Pauling L. A unified theory of human cardiovascular disease leading the
way to the abolition of this disease as a cause for human mortality. J Orthomol
Med 7:1:5-15, 1992.
-
Regnström J, Nilsson J, Moldeus P, et al. Inverse relation between the
concentration of low-density- lipoprotein vitamin E and severity of coronary
artery disease. Am J Clin Nutr 63:377-85, 1996.
-
Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean dietfor
prevention of coronary heart disease. Am J Clin Nutr 61suppl:1360S-7S, 1995.
-
Riemersma RA, Wood DA, MacIntyre CCH, et al. Risk of angina pectoris and plasma
concentrations of vitamins A, C and E and carotene. Lancet 337:1-5, 1991.
-
Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of
coronary heart disease in men. N Engl J Med 32820:1450-6, 1993.
-
Rinehart JF, Greenberg LD. Vitamin B6 deficiency in the Rhesus monkey. Am J Clin
Nutr 4:318-25, 1956; Rinehart JF, Greenberg LD. Arteriosclerotic lesions in
pyridoxine deficient monkeys. Am J Pathol 25:481-96, 1949.
-
Rinehart JF, Greenberg LD. Pathogenesis of experimental arteriosclerosis in
pyridoxine deficiency with notes on similarities to human arteriosclerosis. Arch
Pathol 51:12-29, 1951.
-
Rhinehart JF, Greenberg LD. Vitamin B6 deficiency in the rhesus monkey, with
particular reference to the occurrence of atherosclerosis, dental caries and
hepatic cirrhosis. Am J Clin Nutr 4:318, 1956.
-
Sahyoun NR et al. Carotenoids, vitamins C and E, and mortality in an elderly
population. Am J Epidemiol 144:5:501-11, 1996.
-
Salonen JT et al. Association between cardiovascular death and myocardial
infarction and serum selenium in a matched-pair longitudinal study. Lancet
ii:175-9, 1982.
-
Salonen JT et al. Interactions of serum copper, selenium, and low density
lipoprotein cholesterol in atherogenesis. Br Med J 302:756-60, 1991.
-
Serfontein WJ, Ubbink JB, De Villiers LS, et al. Plasma pyridoxal-5-phosphate
level as risk index for coronary artery disease. Atherosclerosis 55:3:357-61,
1985.
-
Shah DR et al. Effect of oral zinc sulphate on serum lipids and lipoproteins in
human subjects. Indian J Physiol Pharmacol 32;1:47-50, 1988.
-
Simon E et al. Plasma and erythrocyte vitamin E content in asymptomatic
hypercholesterolemic subjects. Clin Chem 43:2:285-9, 1997.
-
Simons LA, Von Konigsmark M, Balasubramaniam S. What dose of vitamin E is
required to reduce susceptibility of LDL to oxidation? Aust N Z J Med
26;4:496-503, 1996.
-
Singh R, Niaz M, Bishnol J, et al. Diet, antioxidant vitamins, oxidative stress,
and risk of coronary artery disease. Acta Cardiol 49:5:453-67, 1994.
-
Singh RB, Ghosh S, Niaz MA, et al. Dietary intake, plasma levels of antioxidant
vitamins and oxidative stress in relation to coronary artery disease in elderly
subjects. Am J Cardiol 76:1233-8, 1995.
-
Singal PK, Dhillon KS, Beamish RE, Dhalla NS. Protective action of zinc against
catecholamine-induced myocardial changes. Electrocardiographic and
ultrastructural studies. Lab Invest 44:426, 1981.
-
Singal PK, Kapur N, Dhillon KS et al. Role of free radicals in catecholamine
induced cardiomyopathy. Can J Physiol Pharmacol 60:1390, 1982.
-
Sklodowska M, Wasowicz W, Gromnadzinska J, et al. Selenium and vitamin E
concentrations in plasma and erythrocytes of angina pectoris patients. Trace
Elem Med 8:113-17, 1991.
-
Stampfer M, Hennekens C, Manson J, et al. Vitamin E consumption and the risk of
coronary heart disease in women. N Engl J Med 328:1444-9, 1993.
-
Stead NW et al. Selenium Se balance in the dependent elderly. Am J Clin Nutr
39:677, 1984.
-
Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr
10;5:466-73, 1991.
-
Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone
in patients with transient ischemic attacks. Am J Clin Nutr 62;suppl:1381S-4S,
1995.
-
Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of
vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study
CHAOS. Lancet 347:781-6, 1996.
-
Stone WL et al. Effects of dietary selenium and vitamin E on plasma lipoprotein
cholesterol levels in male rats. Ann Nutr Metab 30:94-103, 1986.
-
Street DA et al. Serum antioxidants and myocardial infarction: Are low levels of
carotenoids and alpha-tocopherol risk factors for myocardial infarction?
Circulation 90;3:1154-61, 1994.
-
Suadicani P, Hein H, Gyntelberg F. Serum selenium concentration and risk of
ischaemic heart disease in an prospective cohort study of 3000 males.
Atherosclerosis 96:33-42, 1992.
-
Subbarao K et al. Pyridoxal 5'-phosphate - a new physiological inhibitor of
blood coagulation and platelet function. Biochem Pharmacol 28:531-4, 1979.
-
Suzukawa M, Ishikawa T, Yoshida H, Tokorozawa N. Effect of in-vivo
supplementation with low-dose vitamin E on susceptibility of low-density
lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll
Nutr 14:1:46-52, 1995.
-
Takamatsu S, Takamatsu M, Satoh K, et al. Effects on health of dietary
supplementation with 100 mg d-alpha tocopheryl acetate, daily for 6 years. J Int
Med Res 23:342-57, 1995.
-
Tomoda H, Yoshitake M, Morimoto K, Aoki N, et al. Possible prevention of
postangioplasty restenosis by ascorbic acid. Am J Cardiology 78;11:1284-6, 1996.
-
Toohey L et al. Plasma ascorbic acid concentrations are related to
cardiovascular risk factors in African-Americans. J Nutr 126:121-8, 1996.
-
Torun M et al. Serum levels of vitamin E in relation to cardiovascular diseases.
J Clin Pharm Therap 20:335-40, 1995.
-
Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6,
and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr
57:47-53, 1993.
-
Urberg M et al. Hypocholesterolemic effect of nicotinic acid and chromium
supplementation. J Fam Pract 27;6:603-6, 1988.
-
Vallance BD, Hume R, Weyers E. Reassessment of changes in leucocyte and serum
ascorbic acid after acute myocardial infarction. Br Heart J 40;1:64-8, 1978.
-
Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of
myocardial infarction: relation with vitamin B6, B12, and folate. Am J Epidemiol
143:9:845-59, 1996.
-
Verlangieri AJ, Bush MJ. Effects of d-a-tocopherol supplementation on
experimentally induced primate atherosclerosis. J Am Coll Nutr 11;2:131-8, 1992.
-
Vermaak WJH et al. Vitamin B6 and coronary heart disease. Epidemiological
observations and case studies. Atherosclerosis 63:235, 1987.
-
Vijaya I et al. Trace metal analysis in the aorta with and without
atherosclerotic lesions. Trace Elem Electrolytes 12;4:200-2, 1995.
-
Vijayammal PL, Kurup PA. Pyridoxine and atherosclerosis: Role of pyridoxine in
the metabolism of lipids and glycosaminoglycans in rats fed normal and high fat,
high cholesterol diets containing 16% casein. Austral J Biol Sci 31:1:7-20,
1978.
-
Virtamo J et al. Serum selenium and the risk of coronary heart disease and
stroke. Am J Epidemiol 122:276-82, 1985.
-
Willis GC, Light AW, Gow WS. Serial arteriography in atherosclerosis. Can Med
Assoc J 71:562-8, 1954.
-
Willis GC, Fishman S. Ascorbic acid content of human arterial tissue. Can Med
Assoc J 72:500-3, 1955.
-
Woodside J et al. the effects of vitamin supplementation on cardiovascular risk.
J Inherit Metabol Dis 19:Suppl 1:26/P51, 1996.
-
Yau TM, Weisel RD, Mickle DA, et al. Vitamin E for coronary bypass operations. A
prospective, double-blind, randomized trial. J Thorac Cardiovasc Surg
108;2:302-10, 1994.
